Evidence map›Paper›PMID 37468456›Full record

ArticleNature communications2023

Circulating trans fatty acids are associated with prostate cancer in Ghanaian and American men.

Tsion Zewdu Minas, Brittany D Lord, Amy L Zhang, Julián Candia, Tiffany H Dorsey, Francine S Baker, Wei Tang, Maeve Bailey-Whyte, Cheryl J Smith, Obadi M Obadi and 13 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 8 institutions in 4 countries.

Tsion Zewdu Minas *Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute (NCI), Bethesda, MD, USA.
Brittany D Lord *Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute (NCI), Bethesda, MD, USA.ORCID 0000-0002-6133-1757
Amy L ZhangLaboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute (NCI), Bethesda, MD, USA.
Julián CandiaLaboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute (NCI), Bethesda, MD, USA.ORCID 0000-0001-5793-8989
Tiffany H DorseyLaboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute (NCI), Bethesda, MD, USA.
Francine S BakerLaboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute (NCI), Bethesda, MD, USA.ORCID 0000-0003-3133-3652
Wei TangLaboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute (NCI), Bethesda, MD, USA.ORCID 0000-0002-7089-4391
Maeve Bailey-WhyteLaboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute (NCI), Bethesda, MD, USA.
Cheryl J SmithLaboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute (NCI), Bethesda, MD, USA.
Obadi M ObadiLaboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute (NCI), Bethesda, MD, USA.
Anuoluwapo AjaoLaboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute (NCI), Bethesda, MD, USA.
Symone V JordanLaboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute (NCI), Bethesda, MD, USA.
Yao TetteyUniversity of Ghana Medical School, Accra, Ghana.
Richard B BiritwumUniversity of Ghana Medical School, Accra, Ghana.
Andrew A AdjeiUniversity of Ghana Medical School, Accra, Ghana.
James E MensahUniversity of Ghana Medical School, Accra, Ghana.
Robert N HooverDivision of Cancer Epidemiology & Genetics, NCI, Rockville, MD, USA.
Ann W HsingStanford Cancer Institute, Stanford University, Palo Alto, CA, USA.
Jia LiuCancer Genomics Research Laboratory, NCI, Rockville, MD, USA.
Christopher A LoffredoLombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.
Clayton YatesDepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.ORCID 0000-0001-5420-9852
Michael B CookDivision of Cancer Epidemiology & Genetics, NCI, Rockville, MD, USA.
Stefan AmbsLaboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute (NCI), Bethesda, MD, USA. ambss@mail.nih.gov.ORCID 0000-0001-7651-9309
National Cancer Institute · USUniversity of Ghana · GHCancer Genetics (United States) · USGeorgetown University · USJohns Hopkins University · USNational Institute on Aging · USStanford University · USUniversity of Limerick · IE

Funding

Tuskegee University Center for Biomedical Research/ Research Centers at Minority InstitutionsU54MD007585 · NIMHD · TUSKEGEE UNIVERSITY · PI Jason Anthony White · 2017 to 2026
$29.4M
Research Education CoreU54CA118623 · NCI · TUSKEGEE UNIVERSITY · PI Vivian L Carter, TIMOTHY TURNER · 2005 to 2026
$20.2M
NCI NIH HHS U54 CA118623NIMHD NIH HHS U54 MD007585
6 · The paper itself

Abstract

The association between fatty acids and prostate cancer remains poorly explored in African-descent populations. Here, we analyze 24 circulating fatty acids in 2934 men, including 1431 prostate cancer cases and 1503 population controls from Ghana and the United States, using CLIA-certified mass spectrometry-based assays. We investigate their associations with population groups (Ghanaian, African American, European American men), lifestyle factors, the fatty acid desaturase (FADS) genetic locus, and prostate cancer. Blood levels of circulating fatty acids vary significantly between the three population groups, particularly trans, omega-3 and omega-6 fatty acids. FADS1/2 germline genetic variants and lifestyle factors explain some of the variation in fatty acid levels, with the FADS1/2 locus showing population-specific associations, suggesting differences in their control by germline genetic factors. All trans fatty acids, namely elaidic, palmitelaidic, and linoelaidic acids, associated with an increase in the odds of developing prostate cancer, independent of ancestry, geographic location, or potential confounders.

Indexed as

Fatty Acids, Omega-3Prostatic NeoplasmsTrans Fatty AcidsFatty Acid DesaturasesFatty AcidsGhanaHumansMalePolymorphism, Single NucleotideUnited StatesFatty Acid DesaturasesFatty AcidsFatty Acids, Omega-3Trans Fatty Acids

Identifiers

PMID37468456
PMCPMC10356769
OpenAlexW4384819111

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.